Global Animal Therapeutics and Diagnostics [Animal Therapeutic Products (Anti-Parasitic drugs and Antibiotics, Anti-inflammatory drugs, Anesthetics and Other Drugs), Animal Diagnostics Products (Instruments and Consumables)], Animal Type [Companion animals (Dogs, Cats, and Others), Cattle, Pigs, Poultry and Sheep] - Global Opportunity Analysis and Industry Forecast, 2014-2022

Global Animal Therapeutics and Diagnostics [Animal Therapeutic Products (Anti-Parasitic drugs and Antibiotics, Anti-inflammatory drugs, Anesthetics an

Category : Diagnostic and Biotech
Published On : February  2017
Pages : 114



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Animal Therapeutics And Diagnostics Imply A Variety Of Measures Taken To Ensure Sustainable Animal Health. Animal Diagnostic Products Are Useful In Identification Of Any Disease And Aids In The Analysis Of Symptoms Caused Due To Ailments Determining Onset Of Any Disease. These Diagnostic Instruments Include, Small Animal Imaging Devices Such As Positron Emission Tomography (Pet), Single-Photon Emission Computed Tomography (Sect), Computed Tomography (Ct), And Magnetic Resonance Imaging (Mri). Therapeutic Treatment For Animals Involves Use Of Various Drugs, Which Help Cure The Disease Based On Their Mode Of Action. A Number Of Drugs Including Anti-Parasitic, Anti-Inflammatory, And Anesthetics Are Used For Various Treatments.

The Global Animal Therapeutics And Diagnostics Market Is Attributed To The Initiatives Taken By The Government To Spend More On Healthcare And R&D. In Addition, The Increase In The Consumption Of Meat, Milk, Protein, And The Extensively Growing Pet Ownership Drive The Market. However, Lack Of Awareness Regarding Pet Health And Ill Effects Of Excessive Drug Dosage Are Expected To Restrain The Growth Of The Market.

Key Benefits

  • The Global Animal Therapeutics And Diagnostics Market Report Provides An Extensive Analysis Of The Current Market Trends And Future Estimations Prevailing In The Market.
  • The Market Estimations From 2014 To 2022 Are Based On High-End Analysis Of The Key Developments.
  • The Market Scenario Is Comprehensively Analyzed With Respect To The Product Type, Animal Type, And Geography.
  • Recent Developments And Key Manufacturers Are Listed And Analyzed To Understand The Competitive Market Scenario.
  • In-Depth Analysis, Based On Geography Provides An Understanding Of The Regional Market, Which Assists In Strategic Business Planning.

Animal Therapeutics and Diagnostics Market Key Segments

By Product

  • Animal Diagnostics Products
    • Instruments
    • Consumables
  • Animal Therapeutics Products
    • Anti-Parasitic Drugs And Antibiotics
    • Anti-Inflammatory Drugs
    • Anesthetics
    • Other Drugs

By Animal Type

  • Companion Animals
    • Dogs
    • Cats
    • Other Companion Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Taiwan
    • Rest Of Asia-Pacific
  • Lamea
    • Brazil
    • Turkey
    • Venezuela
    • Saudi Arabia
    • Rest Of Lamea

The Key Players Profiled In This Report Include

  • Bayer Ag
  • Eli Lilly And Company
  • Boehringer
  • Ingelheim Gmbh
  • Merck & Co., Inc.
  • Zoetis Inc.
  • Ceva Santé Animale
  • Sanofi S.A.
  • Nutreco N.V.
  • Virbac S.A.

The Other Players Of The Animal Therapeutics And Diagnostics Market Include (Companies Not Profiled In The Report):

  • Qiagen N.V.
  • Active Motif, Inc.
  • Takara Bio Usa, Inc.
  • Candor Bioscience Gmbh
  • Innova Biosciences Ltd.
  • Luminex Corporation
  • Bio-Rad Laboratories
  • Agilent Technologies, Inc.
  • Caprion Biosciences
  • Nanotemper Technologies Gmbh
  • Biotium, Inc.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Government regulations

3.3.1. Center for Veterinary Medicine (CVM)
3.3.2. Environmental Protection Agency (EPA)

3.4. Patents Analysis

3.4.1. PATENT ANALYSIS BY YEAR

3.4.1.1. Patent analysis of animal therapeutics by year
3.4.1.2. Patent analysis of animal diagnostics by year

3.4.2. PATENT ANALYSIS BY REGION

3.4.2.1. Patent analysis of animal diagnostics by region
3.4.2.2. Patent analysis of animal diagnostics by region

3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rising demand for animal derived food products
3.5.1.2. Growing demand for pet insurance
3.5.1.3. Rising concern to prevent zoonotic diseases
3.5.1.4. Growing ownership of companion animals
3.5.1.5. Rising animal health expenditure

3.5.2. Restraints

3.5.2.1. Highly competitive meat and milk prices
3.5.2.2. Lack of animal health awareness
3.5.2.3. Adverse impact of veterinary drugs on human and animal health

3.5.3. Opportunities

3.5.3.1. Advancement in therapeutic and diagnostic products
3.5.3.2. Therapeutic and diagnostic products for hybrid animals

CHAPTER 4 ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. animal diagnostics products

4.2.1. Market size and forecast
4.2.2. Instruments

4.2.2.1. Key market trends
4.2.2.2. Key growth factors and opportunities

4.2.3. Consumables

4.2.3.1. Key market trends
4.2.3.2. Key growth factors and opportunities

4.3. animal therapeutics products

4.3.1. Market size and forecast
4.3.2. Anti-Parasitic drugs and antibiotics

4.3.2.1. Key market trends
4.3.2.2. Key growth factors and opportunities

4.3.3. Anti-Inflammatory drugs

4.3.3.1. Key market trends
4.3.3.2. Key growth factors and opportunities

4.3.4. Anesthetics

4.3.4.1. Key market trends
4.3.4.2. Key growth factors and opportunities

4.3.5. Others

4.3.5.1. Key market trends
4.3.5.2. Key growth factors and opportunities

CHAPTER 5 ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Companion Animals

5.2.1. Market size and forecast
5.2.2. Dogs
5.2.3. Cats
5.2.4. Other Companion Animals

5.3. Cattle

5.3.1. Market size and forecast

5.4. Pigs

5.4.1. Market size and forecast

5.5. Poultry

5.5.1. Market size and forecast

5.6. Sheep

5.6.1. Market size and forecast

CHAPTER 6 ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY GEOGRAPHY

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size & forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast

6.3. Europe

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size and forecast
6.3.5. France market size and forecast
6.3.6. UK market size and forecast
6.3.7. Italy market size and forecast
6.3.8. Rest of Europe market size and forecast

6.4. Asia-Pacific

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size and forecast
6.4.5. China market size and forecast
6.4.6. Australia market size and forecast
6.4.7. India market size and forecast
6.4.8. South Korea market size and forecast
6.4.9. Taiwan market size and forecast
6.4.10. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. Turkey market size and forecast
6.5.6. Venezuela market size and forecast
6.5.7. Saudi Arabia market size and forecast
6.5.8. Rest of LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. Bayer AG

7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves & developments

7.2. Eli Lilly and Company

7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments

7.3. Boehringer, Ingelheim GmbH

7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance

7.4. Merck & Co.

7.4.1. Company overview
7.4.2. Business performance
7.4.3. Key strategic moves & developments

7.5. Zoetis Inc.

7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance

7.6. Ceva Sant Animale

7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance

7.7. Sanofi S.A.

7.7.1. Company overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments

7.8. Nutreco N.V.

7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Business performance

7.9. Virbac S.A.

7.9.1. Company overview
7.9.2. Business performance
7.9.3. Key strategic moves & development

*Details on financial performance, strategic moves and developments may not be captured for unlisted companies.
*Please note this is a tentative TOC and may change with research proceedings.

LIST OF TABLES

TABLE 1. GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 2. GLOBAL ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 3. GLOBAL ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 4. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 5. GLOBAL COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 6. ANIMAL THERAPEUTICS AND DIAGNOSTICS CATTLE MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 7. ANIMAL THERAPEUTICS AND DIAGNOSTICS PIGS MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 8. ANIMAL THERAPEUTICS AND DIAGNOSTICS POULTRY MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 9. ANIMAL THERAPEUTICS AND DIAGNOSTICS SHEEP MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 10. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 11. NORTH AMERICA ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 12. NORTH AMERICA ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 13. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 14. NORTH AMERICA COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 15. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)
TABLE 16. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 17. EUROPE ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 18. EUROPE ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 19. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 20. EUROPE COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 21. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)
TABLE 22. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 23. ASIA-PACIFIC ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 24. ASIA-PACIFIC ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 25. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 26. ASIA-PACIFIC COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 27. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)
TABLE 28. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 29. LAMEA ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 30. LAMEA ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 31. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 32. LAMEA COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 33. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)
TABLE 34. BAYER: COMPANY SNAPSHOT
TABLE 35. BAYER: OPERATING SEGMENTS
TABLE 36. ELI LILLY: COMPANY SNAPSHOT
TABLE 37. ELI LILLY: OPERATING SEGMENTS
TABLE 38. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 39. BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 40. MERCK: COMPANY SNAPSHOT
TABLE 41. MERCK: OPERATING SEGMENTS
TABLE 42. ZOETIS: COMPANY SNAPSHOT
TABLE 43. ZOETIS: OPERATING SEGMENTS
TABLE 44. CEVA SANT ANIMALE: COMPANY SNAPSHOT
TABLE 45. CEVA SANT ANIMALE: OPERATING SEGMENTS
TABLE 46. SANOFI: COMPANY SNAPSHOT
TABLE 47. SANOFI: OPERATING SEGMENTS
TABLE 48. NUTRECO: COMPANY SNAPSHOT
TABLE 49. NUTRECO: OPERATING SEGMENTS
TABLE 50. VIRBAC: COMPANY SNAPSHOT
TABLE 51. VIRBAC: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL PATIENT MECHANICAL LIFT HANDLING EQUIPMENT MARKET: SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE
FIGURE 3. U.S. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 4. CANADA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 5. MEXICO ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 6. GERMANY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 7. FRANCE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 8. UK ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 9. ITALY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 10. REST OF EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 11. JAPAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 12. CHINA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 13. AUSTRALIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 14. INDIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 15. SOUTH KOREA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 16. TAIWAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 17. REST OF ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 18. BRAZIL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 19. TURKEY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 20. VENEZUELA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 21. SAUDI ARABIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 22. REST OF LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 23. BAYER: REVENUE, BY YEAR ($MILLION)
FIGURE 24. BAYER: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 25. BAYER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 26. ELI LILLY: REVENUE, BY YEAR ($MILLION)
FIGURE 27. ELI LILLY: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 28. ELI LILLY: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 29. BOEHRINGER INGELHEIM: REVENUE, BY YEAR ($MILLION)
FIGURE 30. BOEHRINGER INGELHEIM: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 31. BOEHRINGER INGELHEIM: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 32. MERCK: REVENUE, BY YEAR ($MILLION)
FIGURE 33. MERCK: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 34. MERCK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 35. ZOETIS: REVENUE, BY YEAR ($MILLION)
FIGURE 36. ZOETIS: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 37. ZOETIS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 38. CEVA SANT ANIMALE: REVENUE, BY YEAR ($MILLION)
FIGURE 39. CEVA SANT ANIMALE: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 40. CEVA SANT ANIMALE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 41. SANOFI: REVENUE, BY YEAR ($MILLION)
FIGURE 42. SANOFI: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 43. SANOFI: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 44. NUTRECO: REVENUE, BY YEAR ($MILLION)
FIGURE 45. NUTRECO: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 46. NUTRECO: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 47. VIRBAC: REVENUE, BY YEAR ($MILLION)
FIGURE 48. VIRBAC: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 49. VIRBAC: REVENUE, BY GEOGRAPHY, 2015 (%)

Enquiry Before Buy